From: Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia
Characteristic | No corticosteroid | Low-dose corticosteroids | High-dose corticosteroids | Â | |||
---|---|---|---|---|---|---|---|
n = 1829 | n = 267 | n = 132 | p value | ||||
30-day mortality | 14 | (0.8) | 5 | (1.9) | 7 | (5.3) | < 0.0001 |
In-hospital hyperglycemia requiring insulin treatment | 104 | (5.7) | 30 | (11.2) | 31 | (23.5) | < 0.0001 |
Length of stay, days | 13.1 | ±12.8 | 18.0 | ±18.8 | 23.6 | ±18.5 | < 0.0001 |
Length of anitmicrobial treatment, days | 6.8 | ±4.8 | 9.3 | ±7.3 | 9.5 | ±6.3 | < 0.0001 |
Total cost of all drugs in hospitalization | |||||||
 Japanese Yen ± SD | 49,799 | ±99,142 | 107,656 | ±243,792 | 161,980 | ±225,494 | < 0.0001 |
 Euro ± SD | 428 | ±851 | 924 | ±2093 | 1391 | ±1936 |  |
 US Dollar ± SD | 492 | ±979 | 1063 | ±2408 | 1600 | ±2227 |  |